Home
News
December 1
November 15
November 14
November 13
November 12
November 11
November 9
November 3
October 27
September 8
August 4
Poster Spotlight
Archives
2022
2021
2020
2019
2018
2017
Map & Photos
Industry Events
Industry Supported Symposia
Lightning Talks
Innovation Theaters
ACR 5K
Publications
Meeting Magazine
Digital Preview
Follow Us
X (Twitter)
Facebook
LinkedIn
YouTube
Search
Search
November 10-15
Meeting Home
The official news source of
ACR Convergence 2023
San Diego, CA
Register Now
Meeting Home
Register Now
Home
//
Events
//
The First FDA-Approved Biologic for the Treatment of Polymyalgia Rheumatica: A Deep Dive
The First FDA-Approved Biologic for the Treatment of Polymyalgia Rheumatica: A Deep Dive
October 26, 2023
//
1 minute
Share on Twitter
Share on Twitter
Share on Facebook
Share on Facebook
Share on LinkedIn
Share on LinkedIn
Previous:
Pioneering CAR T Cell Therapy in Autoimmune Diseases: A Fireside Chat with Dr. Georg Schett and Dr. Carl June
Next:
The Inflammatory Role of the Eosinophil in EGPA
